These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12491208)

  • 41. [Treatment of chronic hepatitis C: still many problems pending].
    Bruguera M
    Gastroenterol Hepatol; 1997 Jan; 20(1):31-42. PubMed ID: 9072195
    [No Abstract]   [Full Text] [Related]  

  • 42. Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems.
    Nunes D; Saitz R; Libman H; Cheng DM; Vidaver J; Samet JH
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1520-6. PubMed ID: 16930214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C and HIV co-infection: a review.
    Maier I; Wu GY
    World J Gastroenterol; 2002 Aug; 8(4):577-9. PubMed ID: 12174359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C: Part II. Prevention counseling and medical evaluation.
    Moyer LA; Mast EE; Alter MJ
    Am Fam Physician; 1999 Jan; 59(2):349-54, 357. PubMed ID: 9930128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin.
    Weiss JJ; Bhatti L; Dieterich DT; Edlin BR; Fishbein DA; Goetz MB; Yu K; Wagner GJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):289-93. PubMed ID: 19086329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Editorial Commentary: Interferon-free Hepatitis C Treatment Efficacy From Clinical Trials Will Translate to "Real World" Outcomes.
    Martinello M; Dore GJ
    Clin Infect Dis; 2016 Apr; 62(7):927-8. PubMed ID: 26743092
    [No Abstract]   [Full Text] [Related]  

  • 47. Barriers to treatment of hepatitis C in HIV/HCV coinfected adults in Brazil.
    Mendes-Corrêa MC; Martins LG; Ferreira PA; Tenore S; Leite OH; Leite AG; Cavalcante AJ; Shimose M; Silva MH; Uip DE
    Braz J Infect Dis; 2010; 14(3):237-41. PubMed ID: 20835506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of hepatitis C virus associated extrahepatic manifestations].
    Duclos-Vallée JC
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B76-81. PubMed ID: 12180311
    [No Abstract]   [Full Text] [Related]  

  • 49. HIV/HCV co-infection has treatment implications.
    Murphy MJ
    HIV Clin; 2000; 12(2):1, 5. PubMed ID: 11810826
    [No Abstract]   [Full Text] [Related]  

  • 50. [Hepatitis C in the HIV-infected person].
    Teruya K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):682-7. PubMed ID: 15359885
    [No Abstract]   [Full Text] [Related]  

  • 51. Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy. Hepatitis/HIV Spanish Study Group.
    Soriano V; Bravo R; García-Samaniego J; Castilla J; González J; Castro A; Llibre JM
    AIDS; 1997 Mar; 11(3):400-1. PubMed ID: 9147443
    [No Abstract]   [Full Text] [Related]  

  • 52. Hepatitis C care cascade in HIV patients at an urban clinic in the early direct-acting antiviral era.
    Ma J; Non L; Amornsawadwattana S; Olsen MA; Garavaglia Wilson A; Presti RM
    Int J STD AIDS; 2019 Aug; 30(9):834-842. PubMed ID: 31159714
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population.
    Scott JD; Wald A; Kitahata M; Krantz E; Drolette L; Corey L; Wang CC
    AIDS Patient Care STDS; 2009 Nov; 23(11):925-9. PubMed ID: 19827950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and clinical significance of TT virus coinfection in patients with chronic hepatitis C treated with interferon.
    Brandhagen DJ; Gross JB; Zein NN
    Am J Gastroenterol; 1999 Jun; 94(6):1715-6. PubMed ID: 10364064
    [No Abstract]   [Full Text] [Related]  

  • 55. [The therapy of hepatitis C in the failure of interferon].
    Hermann R; Maier KP
    Dtsch Med Wochenschr; 1997 Aug; 122(34-35):1049-54. PubMed ID: 9312461
    [No Abstract]   [Full Text] [Related]  

  • 56. HIV and hepatitis C virus co-infection.
    Carrat F; Perronne C;
    Lancet Infect Dis; 2005 Feb; 5(2):71. PubMed ID: 15680774
    [No Abstract]   [Full Text] [Related]  

  • 57. [Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection: epidemiology, severity and recent therapeutic strategies].
    Cacoub P; Pol S
    Rev Med Interne; 2005 Apr; 26(4):267-70. PubMed ID: 15820560
    [No Abstract]   [Full Text] [Related]  

  • 58. Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands. Longer is better for genotype 3 treatment.
    TreatmentUpdate; 2006; 18(2):3-4. PubMed ID: 17228454
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of antiviral therapy in patients with hepatitis C.
    Diamond C; Lee JH
    Ann Intern Med; 2002 Dec; 137(12):1012. PubMed ID: 12484735
    [No Abstract]   [Full Text] [Related]  

  • 60. Interferon therapy in hepatitis C virus (HCV) induced chronic hepatitis: clinical significance of pretreatment with glycyrhizine.
    Fujisawa K
    Trop Gastroenterol; 1991; 12(4):176-9. PubMed ID: 1726032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.